Ascelia Pharma

Ascelia Pharma Debt

The Debt of Ascelia Pharma (ACE.ST) as of Oct 9, 2026 is 1.04 M SEK. In the previous year, Debt was 25.40 M SEK — a change of -95.90% (lower).

Debt

1.04 MSEK

YoY

-95.90%

Last updated:

In 2025, Ascelia Pharma's total debt was 1.04 M SEK, a -95.90% change from the 25.40 M SEK total debt recorded in the previous year.

The Ascelia Pharma Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt
Date
Debt
Jan 1, 2018
146,000.00 SEK
Jan 1, 2019
215,000.00 SEK
Jan 1, 2020
1.78 M SEK
Jan 1, 2021
1.66 M SEK
Jan 1, 2022
484,000.00 SEK
Jan 1, 2023
1.06 M SEK
Jan 1, 2024
25.40 M SEK
Jan 1, 2025
1.04 M SEK
The Ascelia Pharma Debt history
YEARDebtYoY
1.04 MSEK-95.90%
25.40 MSEK+2,295.94%
1.06 MSEK+119.01%
484,000.00SEK-70.76%
1.66 MSEK-6.92%
1.78 MSEK+726.98%
215,000.00SEK+47.26%
146,000.00SEK—
0.00SEK—
0.00SEK—
Access this data via the Eulerpool API
Get Free API Key

Ascelia Pharma Stock analysis

What does Ascelia Pharma do? Ascelia Pharma is one of the most popular companies on Eulerpool.

Debt Details

Understanding Ascelia Pharma's Debt Structure

Ascelia Pharma's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Ascelia Pharma's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Ascelia Pharma’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Ascelia Pharma’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Ascelia Pharma stock

Debt of Ascelia Pharma is 1.04 M SEK in 2025.

Debt of Ascelia Pharma changed from 25.40 M SEK to 1.04 M SEK, representing a -95.90% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Debt Ascelia Pharma since 2006 – with annual values, charts, and detailed analysis.

Debt's SEK is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Debt's Ascelia Pharma historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — Ascelia Pharma

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Ascelia Pharma